Cargando…
Sortilin as a Novel Diagnostic and Therapeutic Biomarker in Chronic Lymphocytic Leukemia
BACKGROUND: The overexpression of sortilin/neurotensin receptor 3 has previously been reported in various human solid tumors but not in hematological malignancies. Here, we report the overexpression of sortilin in leukemic cells from patients with Chronic Lymphocytic Leukemia (CLL). METHODS: Flow cy...
Autores principales: | Farahi, Lia, Ghaemimanesh, Fatemeh, Milani, Saeideh, Razavi, Seyed Mohsen, Akhondi, Mohammad Mehdi, Rabbani, Hodjattallah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Research Institute
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925395/ https://www.ncbi.nlm.nih.gov/pubmed/31908734 |
Ejemplares similares
-
Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin
por: Farahi, Lia, et al.
Publicado: (2019) -
The Effect of Sortilin Silencing on Ovarian Carcinoma Cells
por: Ghaemimanesh, Fatemeh, et al.
Publicado: (2014) -
Diagnostic and Therapeutic Implications of Sortilin Expressed on the Surface of Bladder Carcinoma Cells
por: Bayat, Ali-Ahmad, et al.
Publicado: (2022) -
Ectopic Expression of Sortilin 1 (NTR-3) in Patients with Ovarian Carcinoma
por: Hemmati, Shayda, et al.
Publicado: (2009) -
Monoclonal Antibody Against Sortilin Induces Apoptosis in Human Breast Cancer Cells
por: Simonian, Miganoosh, et al.
Publicado: (2022)